Bimix #3 (papaverine recalls
The FDA has published 2 recalls involving Bimix #3 (papaverine since 2019. The latest was reported on 1 Jun 2022. Most were for sterility. Olympia Compounding Pharmacy has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls2since 2019
Last 12 months0reported
Class I00% of total
Ongoing0latest 1 Jun 2022
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 100%Class III 0 0%
Why bimix #3 (papaverine is recalled
Companies
By year
All bimix #3 (papaverine recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Bimix-3 Papaverine 30 mg/mL Phentolamine 3 mg/mL recalled | Olympia Compounding Pharmacy | Sterility | Nationwide |
| Drug | CLASS II | Bimix #3 (Papaverine HCl 30 mg/mL/Phentolamine Mesylate recalled | KRS Global Biotechnology | Sterility | Nationwide |
Should you stop taking Bimix #3 (papaverine?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.